Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

ALROSA announced anti-crisis measures.

11/22/24 ALRS

Board of Directors of EvroTrans recommended that dividends be paid for 9 months 2024

11/22/24 EUTR

VK revenue for 9 months of 2024 increased by 21%

11/21/24 VKCO

Segezha presents additional issue parameters for debt repayment

11/21/24 SGZH

Board of Directors of Astra recommended that dividends be paid for 9 month 2024

11/20/24 ASTR

Renaissance Insurance's profit for 9 months of 2024 decreased by more than 50%

11/20/24 RENI

VK launches HeadHunter competitor for Job search

11/20/24 VKCO

MTS-Bank examines insurance assets for M&A

11/19/24 MBNK

Rostelecom to seriously reduce capex in 2025

11/19/24 RTKM

MTS ' net profit for the first 9 months of 2023 increased by 26%

11/19/24 MTSS